US 11180484
Pyrazole derivatives as plasma kallikrein inhibitors
granted A61PA61P7/10
Quick answer
US patent 11180484 (Pyrazole derivatives as plasma kallikrein inhibitors) held by KalVista Pharmaceuticals Limited expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- KalVista Pharmaceuticals Limited
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P7/10